{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T20:00:12Z","timestamp":1765742412845,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"French National Agency for Medicines and Health Products Safety (ANSM)","award":["20145026 (RC14_0344)"],"award-info":[{"award-number":["20145026 (RC14_0344)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12888-015-0677-5","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T07:00:34Z","timestamp":1447484434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PHEDRE trial protocol \u2013 observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population"],"prefix":"10.1186","volume":"15","author":[{"given":"Marie","family":"G\u00e9rardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Couec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Grall-Bronnec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Feuillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Wainstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Lyne","family":"Pinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Perrouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bonnot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Drouineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Jolliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Victorri-Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"677_CR1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0024-3205(86)90181-5","volume":"39","author":"MA Gillman","year":"1986","unstructured":"Gillman MA. Minireview: analgesic nitrous oxide intercats with the endogenous opioid system: a review of the evidence. Life Sci. 1986;39:1209\u201321.","journal-title":"Life Sci"},{"key":"677_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9343(86)90189-0","volume":"81","author":"MA Gillman","year":"1986","unstructured":"Gillman MA. Nitrous oxide, an opioid addictive agent. Am J Med. 1986;81:97\u2013102.","journal-title":"Am J Med"},{"key":"677_CR3","first-page":"304","volume":"209","author":"BA Berkowitz","year":"1977","unstructured":"Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharmacol Exp Ther. 1977;209:304\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"677_CR4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(25)31658-7","volume":"209","author":"MD Hynes","year":"1979","unstructured":"Hynes MD, Berkowitz BA. Nitrous oxide stimulation of locomotor activity: evidence for an opiate-like behavioral effect. J Pharmacol Exp Ther. 1979;209(2):304\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"677_CR5","first-page":"102","volume":"16","author":"MS Wu","year":"2007","unstructured":"Wu MS, Hsu YD, Lin JC, Chen SC, Lee JT. Spinal myoclonus in subacute combined degeneration caused by nitrous oxide intoxication. Acta Neurol Taiwan. 2007;16(2):102\u20135.","journal-title":"Acta Neurol Taiwan"},{"issue":"4","key":"677_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0404.2005.00473.x","volume":"112","author":"MF Waters","year":"2005","unstructured":"Waters MF, Kang GA, Mazziotta JC, DeGiorgio CM. Nitrous oxide inhalation as a cause of cervical myelopathy. Acta Neurol Scand. 2005;112(4):270\u20132.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"677_CR7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1520\/JFS13286J","volume":"37","author":"SA Wagner","year":"1992","unstructured":"Wagner SA, Clark MA, Wesche DL, Doedens DJ, Lloyd AW. Asphyxial deaths from the recreational use of nitrous oxide. J Forensic Sci. 1992;37(4):1008\u201315.","journal-title":"J Forensic Sci"},{"issue":"4","key":"677_CR8","first-page":"43","volume":"102","author":"AJ Waclawik","year":"2003","unstructured":"Waclawik AJ, Luzzio CC, Juhasz-Pocsine K, Hamilton V. Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels. WMJ. 2003;102(4):43\u20135.","journal-title":"WMJ"},{"issue":"8","key":"677_CR9","first-page":"682","volume":"32","author":"AJ Suruda","year":"1990","unstructured":"Suruda AJ, McGlothlin JD. Fatal abuse of nitrous oxide in the workplace. J Occup Med. 1990;32(8):682\u20134.","journal-title":"J Occup Med"},{"issue":"7","key":"677_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archneur.1983.04050070076021","volume":"40","author":"AB Sterman","year":"1983","unstructured":"Sterman AB, Coyle PK. Subacute toxic delirium following nitrous oxide abuse. Arch Neurol. 1983;40(7):446\u20137.","journal-title":"Arch Neurol"},{"issue":"2","key":"677_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03161175","volume":"2","author":"NK Sethi","year":"2006","unstructured":"Sethi NK, Mullin P, Torgovnick J, Capasso G. Nitrous oxide \u201cwhippit\u201d abuse presenting with cobalamin responsive psychosis. J Med Toxicol. 2006;2(2):71\u20134.","journal-title":"J Med Toxicol"},{"issue":"1","key":"677_CR12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1742-6723.2009.01262.x","volume":"22","author":"PG Richardson","year":"2010","unstructured":"Richardson PG. Peripheral neuropathy following nitrous oxide abuse. Emerg Med Australas. 2010;22(1):88\u201390.","journal-title":"Emerg Med Australas"},{"issue":"2","key":"677_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajem.2003.12.015","volume":"22","author":"MA Miller","year":"2004","unstructured":"Miller MA, Martinez V, McCarthy R, Patel MM. Nitrous oxide \u201cwhippit\u201d abuse presenting as clinical B12 deficiency and ataxia. Am J Emerg Med. 2004;22(2):124.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"677_CR14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0305-4179(95)00090-9","volume":"22","author":"JC Hwang","year":"1996","unstructured":"Hwang JC, Himel HN, Edlich RF. Frostbite of the face after recreational misuse of nitrous oxide. Burns. 1996;22(2):152\u20133.","journal-title":"Burns"},{"issue":"5","key":"677_CR15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0761-8425(07)91130-4","volume":"24","author":"L Garbaz","year":"2007","unstructured":"Garbaz L, Mispelaere D, Boutemy M, Jounieaux V. Pneumothorax following recreational inhalation of nitrous oxide. Rev Mal Respir. 2007;24(5):622\u20134.","journal-title":"Rev Mal Respir"},{"issue":"4","key":"677_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00000433-198912000-00010","volume":"10","author":"A Chadly","year":"1989","unstructured":"Chadly A, Marc B, Barres D, Durigon M. Suicide by nitrous oxide poisoning. Am J Forensic Med Pathol. 1989;10(4):330\u20131.","journal-title":"Am J Forensic Med Pathol"},{"issue":"6","key":"677_CR17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5694\/j.1326-5377.2007.tb01283.x","volume":"187","author":"M Cartner","year":"2007","unstructured":"Cartner M, Sinnott M, Silburn P. Paralysis caused by \u201cnagging\u201d. Med J Aust. 2007;187(6):366\u20137.","journal-title":"Med J Aust"},{"key":"677_CR18","doi-asserted-by":"crossref","unstructured":"Alt RS, Morrissey RP, Gang MA, Hoffman RS, Schaumburg HH. Severe myeloneuropathy from acute high-dose Nitrous Oxide (N(2)O) abuse. J Emerg Med. 2011;41(4):378-80.","DOI":"10.1016\/j.jemermed.2010.04.020"},{"issue":"3","key":"677_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0376-8716(93)90009-F","volume":"31","author":"CS Dohrn","year":"1993","unstructured":"Dohrn CS, Lichtor JL, Coalson DW, Uitvlugt A, de Wit H, Zacny JP. Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend. 1993;31(3):265\u201380.","journal-title":"Drug Alcohol Depend"},{"key":"677_CR20","doi-asserted-by":"crossref","unstructured":"Angoulvant F, Redant S, Holvoet L, Millet B, Ferster A, Andreu-Gallien J. Prise en charge de la douleur des enfants dr\u00e9panocytaires aux urgences : recommandations et \u00e9tat des lieux dans le R\u00e9seau M\u00e8re-Enfant de la francophonie. Reanimation. 2011.","DOI":"10.1007\/s13546-011-0309-4"},{"key":"677_CR21","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Syndromes dr\u00e9panocytaires majeurs de l\u2019enfant et l\u2019adolescent. Protocole national de diagnostic et de soins pour une maladie rare. Guide m\u00e9decin Affection Longue Dur\u00e9e, Janvier 2010. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2010-04\/ald_10_pnds_drepano_enfant_web.pdf . Accessed 12 Nov 2015."},{"key":"677_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.2044-8287.1996.tb00495.x","volume":"1","author":"L Midence","year":"1996","unstructured":"Midence L, Elander J. Adjustement and coping in adults with sickle cell disease: An assessment of research evidence. Br J Health Psychol. 1996;1:95\u2013111.","journal-title":"Br J Health Psychol"},{"key":"677_CR23","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Syndromes dr\u00e9panocytaires majeurs de l\u2019adulte. Protocole national de diagnostic et de soins pour une maladie rare. Guide m\u00e9decin Affection Longue Dur\u00e9e, Janvier 2010. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2010-04\/ald_10_guide_drepano_adulte_web.pdf . Accessed 12 Nov 2015."},{"key":"677_CR24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00019-5","volume":"14","author":"BS Shapiro","year":"1997","unstructured":"Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: Perceptions of medical practionners. J Pain Symptom Manage. 1997;14:168\u201374.","journal-title":"J Pain Symptom Manage"},{"key":"677_CR25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0735-6757(95)90163-9","volume":"13","author":"RD Waldrop","year":"1995","unstructured":"Waldrop RD, Mandry C. Health professional\u2019s perceptions of opioid dependence among patients with pain. Am J Emerg Med. 1995;13:529\u201331.","journal-title":"Am J Emerg Med"},{"key":"677_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002508-199206000-00003","volume":"8","author":"DA Fishbain","year":"1992","unstructured":"Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain. 1992;8:77\u201385.","journal-title":"Clin J Pain"},{"key":"677_CR27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","volume":"36","author":"DE Weissman","year":"1989","unstructured":"Weissman DE, Haddox JD. Opiod pseudoaddiction: An iatrogenic syndrome. Pain. 1989;36:363\u20136.","journal-title":"Pain"},{"key":"677_CR28","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV)","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington DC: American Psychiatric Association; 1994."},{"key":"677_CR29","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0277-9536(02)00553-1","volume":"57","author":"J Elander","year":"2003","unstructured":"Elander J, Lusher J, Bevan D, Telfer P. Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc Sci Med. 2003;57:1683\u201396.","journal-title":"Soc Sci Med"},{"issue":"3","key":"677_CR30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.ajp.0000176360.94644.41","volume":"22","author":"J Lusher","year":"2006","unstructured":"Lusher J, Elander J, Bevan D, Telfer P, Burton B. Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain. 2006;22(3):316\u201324.","journal-title":"Clin J Pain"},{"issue":"2","key":"677_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpainsymman.2003.12.001","volume":"27","author":"J Elander","year":"2004","unstructured":"Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than guenine analgesic dependence. J Pain Symptom Manag. 2004;27(2):156\u201369.","journal-title":"J Pain Symptom Manag"},{"key":"677_CR32","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM 5)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM 5). Washington DC: American Psychiatric Association; 2013."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0677-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T11:52:52Z","timestamp":1748692372000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-244X\/15\/281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["677"],"URL":"https:\/\/doi.org\/10.1186\/s12888-015-0677-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2015,11,14]]},"article-number":"281"}}